Search

everythinglearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Many patients on methotrexate experience significant side effects but still continue the medication.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

New treatments for lupus show promise, but more research is needed, especially for children.

Low dose methotrexate does not increase hair fall and may reduce it.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Low-dose flutamide helps reduce excessive hair growth and is even more effective with birth control, without bad effects on blood fats.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

A man with multiple autoimmune diseases developed liver injury from azathioprine, but his liver improved after stopping the drug.

High-dose methotrexate can cause severe skin and nail issues.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Methotrexate for rheumatoid arthritis often causes side effects like diarrhea, fatigue, and hair loss, especially at higher doses.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients, but longer follow-up is needed.

Low-dose flutamide improved hirsutism and satisfaction in women but had common side effects, causing some to stop treatment.

A woman with lupus and Kikuchi-Fujimoto disease improved with treatment.

Infliximab may cause hair loss in Crohn's disease patients.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.

Azathioprine can help with relapses and disability in NMOSD but has more side effects and needs more research.

Folate may reduce methotrexate side effects in psoriasis patients, but its impact on effectiveness is unclear.